The Veterinary Medicines Directorate (VMD) has launched a survey to better understand how UK pet owners use and dispose of flea and tick spot-on treatments, as part of its commitment to evidence-based policy making on pharmaceuticals in the environment.
The research comes as recent studies suggest that some chemicals in these treatments, particularly fipronil and imidacloprid, may be entering UK waterways and potentially harming insects that live in water.
Spot-on flea and tick treatments play a vital role in protecting pets from parasitic diseases, which can also pose risks to human health. The VMD recognises the importance of maintaining this protection whilst understanding and addressing potential environmental impacts.
“We are committed to gathering robust evidence on how these important veterinary medicines are used in practice,” said Gavin Hall, VMD’s deputy chief executive.
The survey is open to UK residents aged 18 and over who currently own cats or dogs and use spot-on flea and tick treatments.
Pet owners will be asked about:
- where and how they purchase treatments;
- how they apply and dispose of treatments;
- what influences their purchasing decisions; and
- their awareness of potential environmental impacts.
Mr Hall said this research supports the VMD’s broader efforts to minimise the environmental impact of veterinary medicines and delivers against the commitments laid out in the UK cross-government Pharmaceuticals in the Environment roadmap.
“The findings will help build the evidence base for future guidance and policies that balance animal welfare, human health, and environmental protection,” Mr Hall added.
The survey takes approximately 10-15 minutes to complete, and all responses are anonymous and confidential. Available until January 1, 2026, you can take the survey, by clicking here.
